Sign in

Paul Zimmer

Research Analyst at Retail Investor

Paul Zimmer is Vice President at FS Investors, specializing in private equity investments across consumer, industrials, business services, and healthcare sectors. He has covered a range of companies in these industries during his tenure, bringing experience from executing M&A transactions at J.P. Morgan and investment roles at Ares Management. Zimmer began his career at J.P. Morgan before joining Ares Management and later transitioned to FS Investors, where he helps manage an extensive investment portfolio. He graduated Magna Cum Laude with High Distinction from Duke University, holding a B.S., and maintains a strong track record in strategic investment analysis and execution.

Paul Zimmer's questions to Origin Agritech (SEED) leadership

Question · Q3 2016

Retail Investor Paul Zimmer asked for more detail on how the ChemChina acquisition of Syngenta would affect Origin and whether the two companies' technologies are competitive or complementary. He also asked when management planned to visit Wall Street.

Answer

CEO Bill Niebur explained that the ChemChina-Syngenta deal is expected to bring more investment and progress to the Chinese market. He stated that Syngenta's technology is viewed as complementary, creating opportunities to combine traits for superior products. Regarding a Wall Street visit, Niebur indicated plans to conduct one in the fourth quarter after finalizing the company's strategic story.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts